Closed

Notice of Intent to Sole Source – Roche Diagnostics BenchMark ULTRA Reagents & Consumables

Description: The National Institutes of Health intends to obtain Roche Ventana BenchMark ULTRA reagents, consumables, and associated service support for immunohistochemistry and in-situ hybridization testing at the Clinical Center in Bethesda, Maryland. The planned contract covers one year, from September 1, 2026, through August 31, 2027, to support the Hematology Bone Marrow Pathology and Consultation Service. This is an active presolicitation notice of intent to use a sole-source acquisition under FAR Part 13, and interested parties must submit capability information by the stated closing date; it is not a grant program or a request for quotations.

Buyer
Released
Aug 11, 2026
Closes
Aug 23, 2026(Closed)

Files

Original attachments and procurement documents tied to this bid.

Federal RFP files are for Starbridge customers only.

You can request RFP files from all other buyer types for free on this site.

See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts